Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jakko van Ingen

Showing results (1-10 of 253) with videos related to

Pageof 26
Sort By:
The Lancet. Respiratory Medicine|March 17, 2015
Treatment of pulmonary disease caused by non-tuberculous mycobacteriaJakko van Ingen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2011
Strategies to improve outcome of drug treatment for Mycobacterium abscessus pulmonary diseaseJakko van Ingen
Clinics in Chest Medicine|February 14, 2015
Microbiological diagnosis of nontuberculous mycobacterial pulmonary diseaseJakko van Ingen
The Journal of Antimicrobial Chemotherapy|February 22, 2024
Why do we use 100 mg of clofazimine in TB and NTM treatment?Jakko van Ingen
Seminars in Respiratory and Critical Care Medicine|March 6, 2013
Diagnosis of nontuberculous mycobacterial infectionsJakko van Ingen
Recent Patents on Anti-Infective Drug Discovery|April 27, 2011
The broad-spectrum antimycobacterial activities of phenothiazines, InVitro: somewhere in all of this there may be patentable potentialsJakko van Ingen
The European Respiratory Journal|February 2, 2013
Re-think first-line tuberculosis treatmentJakko van Ingen, Richard M Anthony
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2012
On the road to unravelling the aetiology of non-tuberculous mycobacterial diseaseDick van Soolingen, Jakko van Ingen
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 25, 2024
Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus diseaseMarta Pozuelo Torres, Jakko van Ingen
International Journal of Pediatric Otorhinolaryngology|March 8, 2011
Cervicofacial lymphadenitis caused by nontuberculous mycobacteria; host, environmental or bacterial factors?Jakko van Ingen, Dick van Soolingen
Pageof 26

Showing results (1-10 of 253) with videos related to

Sort By:
Pageof 26
The Lancet. Respiratory Medicine|March 17, 2015
Treatment of pulmonary disease caused by non-tuberculous mycobacteriaJakko van Ingen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 3, 2011
Strategies to improve outcome of drug treatment for Mycobacterium abscessus pulmonary diseaseJakko van Ingen
Clinics in Chest Medicine|February 14, 2015
Microbiological diagnosis of nontuberculous mycobacterial pulmonary diseaseJakko van Ingen
The Journal of Antimicrobial Chemotherapy|February 22, 2024
Why do we use 100 mg of clofazimine in TB and NTM treatment?Jakko van Ingen
Seminars in Respiratory and Critical Care Medicine|March 6, 2013
Diagnosis of nontuberculous mycobacterial infectionsJakko van Ingen
Recent Patents on Anti-Infective Drug Discovery|April 27, 2011
The broad-spectrum antimycobacterial activities of phenothiazines, InVitro: somewhere in all of this there may be patentable potentialsJakko van Ingen
The European Respiratory Journal|February 2, 2013
Re-think first-line tuberculosis treatmentJakko van Ingen, Richard M Anthony
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|October 31, 2012
On the road to unravelling the aetiology of non-tuberculous mycobacterial diseaseDick van Soolingen, Jakko van Ingen
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|March 25, 2024
Dual β-lactam therapy to improve treatment outcome in Mycobacterium abscessus diseaseMarta Pozuelo Torres, Jakko van Ingen
International Journal of Pediatric Otorhinolaryngology|March 8, 2011
Cervicofacial lymphadenitis caused by nontuberculous mycobacteria; host, environmental or bacterial factors?Jakko van Ingen, Dick van Soolingen
Pageof 26